CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation
Nathanael Raschzok, Anja Reutzel‐Selke, Rosa Bianca Schmuck, Mehmet Haluk Morgul, Ulrich Gauger, Kukuh Aji Prabowo, Laura‐Marie Tannus, Annekatrin Leder, Benjamin Struecker, Sabine Boas‐Knoop, Michael Bartels, Sven Jonas, Christian Lojewski, Gero Puhl, Daniel Seehofer, Marcus Bahra, Andreas Pascher, Johann Pratschke, Igor Maximilian Sauer – 6 May 2015 – The diagnosis of acute cellular rejection (ACR) after liver transplantation is based on histological analysis of biopsies because noninvasive biomarkers for allograft rejection are not yet established for clinical routines.